Pages
Massachusetts and the high price of health care
Dan Gorenstein Sep 11, 2012
Six years after sweeping health care reform, Massachusetts is still struggling to lower the cost of care.
Health care expert changes mind on vouchers program
David Lazarus Aug 31, 2012
A former supporter and architect of the Medicare vouchers program explains why he's now opposed to the program, which Republican presidential candidate Mitt Romney supports.
Walmart arms itself with vaccines
Dan Gorenstein Aug 23, 2012
The giant discounter will soon begin offering a slew of shots aimed at boosting its health care business.
Obama administration takes initiative against health care fraud
Nancy Marshall-Genzer Jul 26, 2012
Attorney General Eric Holder and Health and Human Services Secretary Kathleen Sebelius are spearheading an effort to fight against health care fraud by teaming up with private insurers.
Who gets Medicaid and who doesn't?
Dan Gorenstein Aug 8, 2012
It's supposed to be a health care program for the poor. But over the years, the definition of poor has changed.
Texas opts out of key health care reform provisions
Jeff Horwich Jul 12, 2012
It's been almost two weeks since the Supreme Court ruled President Obama's health care overhaul constitutional. Today Texas Governor Rick Perry has officially announced his plans to opt out of the Medicaid expansion and insurance exchanges included in the Affordable Care Act.
WellPoint gears up for Medicaid bonanza
Dan Gorenstein Jul 9, 2012
The giant health insurer will acquire competitor Amerigroup Corp. for nearly $5 billion in a bid for more Medicaid business.
A week after Supreme Court decision, Americans still divided
Frank Newport Jul 5, 2012
It's been exactly a week since the Supreme Court announced that President Obama's healthcare overhaul is constitutional. Have Americans shifted their view of the law?
What's so bad about off-label uses of medication?
David Brancaccio Jul 3, 2012
GlaxoSmithKline, the huge British drug-maker, will pay $3 billion in fines and compensation to the U.S. government and the states. They are in trouble for marketing drugs for off-label uses of its drugs.
GlaxoSmithKline reaches $3 billion settlement for fraud
Mitchell Hartman Jul 3, 2012
GlaxoSmithKline, the huge British drug maker, will pay $3 billion in fines and compensation to the U.S. government and the states. According to the Justice Department, it's the biggest settlement in a health-care fraud case in history.
